We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Test Based on Antibodies Specific to Colon Cancer

By HospiMedica staff writers
Posted on 10 Aug 2001
Researchers say data suggest the presence of antibodies specific to colon cancer circulating in colon cancer patients, strengthening the clinical validation of a new blood-based colon cancer screening test in development.

The colon cancer test is being developed by Amplistar, Inc. More...
(Winston-Salem, NC, USA), a post-genomics company focused on identifying antibody targets for the early detection and treatment of cancer. The company, which has also developed a screening test for ovarian cancer, utilizes both genomic and functional genomic information to validate its targets. Amplistar believes its anticancer antibody tests will overcome the clinical, technical, and economic challenges of cancer screening by identifying early, cancer-specific targets, thereby greatly enhancing clinical specificity and sensitivity.

"By providing a simple low-cost reliable blood-based test which patients will not be reluctant to undergo, we expect to overcome the barrier of noncompliance which currently prevents the implementation of routine screening on a wide-scale basis,” said Eric Button, CEO of Amplistar.





Related Links:
Amplistar

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Immobilization System
Cranial 4Pi Immobilization
Wound Irrigation Solution
Prontosan®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.